基于腹部盆腔转移术前评估与多参数MRI的高级别浆液性卵巢癌肉眼残留预测模型
本研究纳入128例晚期高级别浆液性卵巢癌患者,基于术前腹部盆腔增强CT、MRI和/或PET-CT评估转移并评分,结合T2WI、DWI、ADC提取影像组学特征及临床指标构建列线图预测残留肿瘤状态。MAP评分、HE-4和NLR为独立预测因子,列线图在训练集AUC 0.936、交叉验证0.906、独立验证集0.900,校准良好。
要点
- MAP评分、HE-4水平、NLR是残留肿瘤的独立预测因子。
- 基于MRI影像组学联合临床参数的列线图术前预测残留肿瘤效能优良。
- 列线图在训练、交叉验证及独立验证队列AUC均达0.900以上。
核心结论
- 基于MRI的影像组学-临床列线图可术前有效预测高级别浆液性卵巢癌残留肿瘤状态。
研究设计与样本
- 回顾性纳入128例晚期高级别浆液性卵巢癌患者,训练队列106例,验证队列22例。
- 术前评估腹部盆腔转移基于增强CT、MRI和/或PET-CT并评分。
- 影像组学特征从T2WI、DWI和ADC图像中提取,采用LASSO逻辑回归筛选特征并构建模型。
诊断标准与关键数值
- MAP评分(p=0.002)、HE-4水平(p=0.001)、NLR(p=0.008)为残留肿瘤状态的独立预测因子。
- 影像组学-临床列线图预测残留肿瘤的AUC在训练队列为0.936,交叉验证为0.906,独立验证队列为0.900。
- 校准曲线拟合良好(p>0.05),决策曲线证实临床适用价值。
临床应用与阅片要点
- 术前可结合MAP评分、HE-4及NLR辅助评估残留肿瘤风险,优化手术规划。
- 影像组学分析需在T2WI、DWI及ADC图像上逐层勾画肿瘤感兴趣区。
局限性
- 验证队列样本量较小(n=22),结论需更大样本外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To preoperatively predict residual tumor (RT) in patients with high-grade serous ovarian carcinoma (HGSOC) via a radiomic-clinical nomogram.
METHODS: A total of 128 patients with advanced HGSOC were enrolled (training cohort: n=106; validation cohort: n=22). Serum cancer antigen-125 (CA125), serum human epididymis protein 4 (HE-4) level, and neutrophil-to-lymphocyte ratio (NLR) were obtained from the medical records. Metastases in abdomen and pelvis (MAP) of HGSOC patients was evaluated and scored based on preoperative abdominal and pelvic enhanced CT, MRI and/or PET-CT. A volume of interest (VOI) of each tumor was manually contoured along the boundary slice-by-slice. Radiomic features were extracted from the T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) images. Univariate and multivariate analyses were used to determine the independent predictors of RT status. Least absolute shrinkage and selection operator (LASSO) logistic regression was performed to select optimal features and construct radiomic models. A radiomic-clinical nomogram incorporating radiomic signature and clinical parameters was developed and evaluated in training and validation cohorts.
RESULTS: MAP score (p = 0.002), HE-4 level (p = 0.001) and NLR (p = 0.008) were independent predictors of RT status. The final radiomic-clinical nomogram showed satisfactory prediction performance in training (AUC = 0.936), cross validation (AUC = 0.906) and separate validation cohorts (AUC = 0.900), and fitted well in calibration curves (p > 0.05). Decision curve further confirmed the clinical application value of the nomogram.
CONCLUSION: The proposed MRI-based radiomic-clinical nomogram achieved excellent preoperative prediction of the RT status in HGSOC.
引用
- Lu, Cai, Wang, et al. Development of a prediction model for gross residual in high-grade serous ovarian cancer by combining preoperative assessments of abdominal and pelvic metastases and multiparametric MRI. Acad Radiol. 2022. PMID: 36587996. doi:10.1016/j.acra.2022.12.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。